A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of ...

The Chief Medical Officer and Director of Global Healthcare and Non-profits at Amazon Web Services, Dr Rowland Illing, has said that the immense computational capacity of the cloud, along with the ...

Precise mapping of a patient’s brain can enable a wider range of treatments, writes DR ROWLAND ILLING, chief medical officer ...

When Izzy’s ‘Pops’, who had lived with Parkinson’s for more than a decade, lost his ability to write, she and her friend ...

CBS News Miami spoke to Jeff Lee, a devoted caregiver who has spent the last several years caring for his longtime partner, ...

THURSDAY, April 17, 2025 (HealthDay News) -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says.

Apr. 14, 2025 — A groundbreaking open-source computer program uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders. The tool ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

For the third year, the Michael J. Fox Foundation organized a concert benefit at Belmont University's Fisher Center for ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Apr. 9, 2025 — A small protein involved in neurodegeneration leading to Parkinson's disease also drives a type of skin cancer known as melanoma, according to new ... Apr. 7, 2025 — A study ...